Lip augmentation is one of the most commonly requested non-surgical aesthetic procedures, and product selection plays a meaningful role in achieving the natural, well-proportioned results patients increasingly seek. This article provides a clinical comparison of two widely used HA lip fillers: Juvederm Volbella with Lidocaine and Restylane Kysse — the lip-specific product within the Restylane range — covering their formulations, clinical properties, technique considerations, and safety profiles to support informed practitioner decision-making.
Product Overview: Volbella and Restylane Kysse
Both Juvederm Volbella and Restylane Kysse are FDA-approved hyaluronic acid fillers specifically designed for lip augmentation and perioral line treatment. Both contain lidocaine for patient comfort. Despite these similarities, they differ significantly in their crosslinking technology, gel structure, and clinical behavior — differences that are clinically meaningful when selecting between them for specific patients and treatment goals.
Juvederm Volbella with Lidocaine
Volbella is formulated using Allergan’s Vycross technology, which blends low and high molecular weight HA chains in a tightly crosslinked matrix. This produces a smooth, homogeneous, low-G’ gel that integrates readily into lip tissue and adapts to lip movement. Vycross technology is also associated with reduced post-injection swelling compared to earlier Hylacross-formulated products — a practical advantage in the lip, where swelling is particularly noticeable to patients.
Volbella’s low G’ makes it well suited to subtle lip enhancement, perioral line correction, and patients seeking a soft, understated result. Its Vycross formulation also contributes to a longer duration of effect — up to 12 months — compared to earlier generation HA lip products. It is FDA-approved for lip augmentation and treatment of perioral lines in adults over 21.
Restylane Kysse
Restylane Kysse is formulated using Galderma’s XpresHAn Technology™, which produces a smooth, flexible gel specifically designed for the dynamic demands of lip tissue. Unlike Restylane’s original NASHA (Non-Animal Stabilized Hyaluronic Acid) technology — which produces a biphasic, particulate gel — XpresHAn Technology creates a more homogeneous gel with optimized elasticity. This means the gel deforms and recovers under the mechanical stress of lip movement, maintaining a natural feel and appearance during expression.
Restylane Kysse is FDA-approved for lip augmentation and perioral line treatment in adults over 21. Results typically last 6 to 12 months. Its flexible gel behavior makes it particularly suited to patients who prioritize natural-feeling results during movement and expression.
Clinical Comparison: Volbella vs. Restylane Kysse
When selecting between these two products for a specific patient, the key differentiators are gel technology, dynamic behavior, and the degree of enhancement desired:
- Gel structure — Volbella uses Vycross crosslinking for a smooth, cohesive low-G’ gel. Kysse uses XpresHAn Technology for a flexible, homogeneous gel engineered to move with lip tissue. These are distinct crosslinking platforms, not simply different particle sizes
- Dynamic behavior — Kysse’s XpresHAn Technology is specifically designed to deform and recover under mechanical stress, giving it an advantage in areas subject to constant movement. Volbella integrates smoothly and its Vycross structure provides natural movement without the product-specific engineering for dynamic zones that Kysse offers
- Enhancement profile — both products suit subtle-to-moderate lip enhancement. Volbella is often selected for very soft, understated results and perioral line correction. Kysse suits practitioners who want to take advantage of its dynamic gel behavior in the mobile lip environment
- Swelling — Vycross technology in Volbella is associated with less post-injection swelling than some other HA formulations, which can be a useful clinical and consultation advantage for patient experience
- Duration — both products last 6 to 12 months in the lip area, with individual variation based on patient metabolism and injection volume
- Reversibility — both are HA-based and reversible with hyaluronidase
Lip Augmentation Techniques
Effective lip augmentation with either product requires thorough pre-treatment assessment, conservative dosing, and precise technique adapted to the individual patient’s anatomy and goals.
Pre-treatment assessment — evaluate baseline lip proportions, skin quality, prior filler history, and aesthetic goals. Identify whether the priority is volumization, border definition, perioral line correction, or a combination. Palpate for residual prior filler before adding new volume.
Injection technique — for vermilion border definition, linear threading at superficial depth along the border is standard. For lip body augmentation, serial puncture or linear threading with small, evenly distributed deposits is preferred. Avoid bolus injection into the lip body — this increases the risk of lumpiness. Both Volbella and Kysse can be delivered via fine needle or blunt-tip cannula depending on the target zone.
Dosing — start conservatively. The lidocaine in both products temporarily reduces patient perception of fullness during the procedure, making it easy to overfill. Assess final results at two weeks once swelling has resolved, and offer a touch-up at that point if needed rather than attempting full correction in a single session.
Post-treatment guidance — advise patients to avoid pressure on the lips, strenuous activity, excessive heat, and alcohol for 24 to 48 hours. Swelling peaks at 24 to 48 hours and typically resolves within one week. Final results should be assessed at two weeks.
Safety Profile and Vascular Considerations
Both Volbella and Restylane Kysse have favorable safety profiles consistent with the broader HA filler category. Common adverse events are mild, temporary, and injection-site related: swelling, bruising, tenderness, and redness. These are particularly common in the lips due to the high vascularity of the tissue and typically resolve within a few days to one week.
Contraindications include known hypersensitivity to hyaluronic acid or any product component, active infection or inflammation at or near the injection site, and pregnancy or breastfeeding. Patients on anticoagulant therapy have elevated bruising risk. A thorough medical history and allergy screening are required before treatment with either product.
Vascular occlusion is the most serious complication of any HA filler injection. The perioral region is supplied by branches of the facial artery and labial arteries — all at risk during lip filler injection. Signs of vascular occlusion include blanching, livedo reticularis, severe or disproportionate pain, or skin discoloration beyond the immediate injection area.
If vascular occlusion is suspected: stop injection immediately and administer high-dose hyaluronidase without delay — do not wait for symptoms to progress. Apply warm compresses to promote vasodilation and refer promptly for specialist management if required. Do not massage the area as a primary response — this is not a reliable management step and should not delay hyaluronidase administration. Both Volbella and Kysse are HA-based and dissolve with hyaluronidase. Hyaluronidase must be immediately available at every lip filler session.
Current guidance from major aesthetic medicine societies does not support mandatory aspiration as a reliable standalone vascular safety measure. Primary prevention relies on slow injection speed, low pressure, small bolus volumes, and thorough anatomical knowledge of lip vascular structures.
Conclusion
Juvederm Volbella and Restylane Kysse are both clinically well-supported, FDA-approved lip fillers with strong safety profiles and distinct technological approaches. Volbella’s Vycross formulation offers a smooth, low-G’ gel with reduced post-injection swelling and up to 12 months duration. Kysse’s XpresHAn Technology offers a flexible, dynamic gel specifically engineered for the mechanical demands of lip tissue. The choice between them depends on patient anatomy, the specific outcome being targeted, and practitioner familiarity — in experienced hands, both can deliver natural, satisfying lip augmentation results.
Health Supplies Plus supplies authentic Juvederm Volbella and Restylane products to licensed medical professionals at wholesale pricing. Register your practice for free to complete one-time license verification and access our full dermal fillers catalog.
Lip Filler Frequently Asked Questions

About the Author: Doris Dickson is a specialist writer for Health Supplies Plus, focusing on the aesthetic medicine industry. She diligently researches cosmetic treatments and products to provide clear, concise information relevant to licensed medical professionals. Her work supports Health Supplies Plus’s commitment to being a reliable informational resource and trusted supplier for the aesthetic community.
Disclaimer: The content provided in this article is intended for informational purposes only and is directed towards licensed medical professionals. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment, nor does it constitute an endorsement of any specific product or technique. Practitioners must rely on their own professional judgment, clinical experience, and knowledge of patient needs, and should always consult the full product prescribing information and relevant clinical guidelines before use. Health Supplies Plus does not provide medical advice.
